查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442904

智慧药丸 - 全球市场考量、竞争状况、市场预测 (2030)

Smart Pills - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2024-2030年期间，全球智慧药丸市场规模将以11.34%的复合年增长率大幅成长。多种因素推动了对智慧药丸的需求，其中最重要的是人口老化的增加以及癌症和糖尿病等与生活方式相关的疾病发生率的上升。这些人口结构的变化迫切需要先进的医疗解决方案，并推动了智慧药丸的采用。

此外，市场预计将受益于研发活动的增加以及用于智慧药丸创新的资金的增加。微型相机整合、小型化和先进微处理器的普及等技术进步对于扩大整体市场格局至关重要。这些技术进步提高了智慧药丸的诊断和治疗能力，使其成为现代医学的重要工具。

对微创手术的需求快速增长以及对患者便利性的重视进一步加速了市场的成长。这些因素的结合证明了智慧药丸的变革潜力，不仅可以推动市场向前发展，而且可以彻底改变医疗诊断和治疗方法。

此外，由于新产品的推出和批准的大量涌入，预计智慧药丸市场将持续成长。这种动态格局的特点是越来越注重透过创新解决方案解决未满足的医疗需求，从而推动市场扩张。2024 年至 2030 年的预测期间将见证一个强大的智慧药丸产品生态系统，预计将为医疗保健产业这一变革性细分市场的整体成长和发展做出重大贡献。

智慧药丸市场动态

全球各种胃肠道疾病的迅速增加预计将显着提振智慧药丸市场。European Federation of Crohn's and Ulcerative Colitis Associations（EFCCA）的最新数据显示，全球有多达 1,000 万人患有发炎性肠道疾病 (IBD)。此外，National Institute for Health and Care Excellence称，在英国，肠躁症 (IBS) 通常发病于 20 岁至 30 岁之间，一般人群中每年的盛行率为 10% 至 20%。情况的严重性。令人担忧的是，许多人即使出现肠躁症症状也不就医，而且据信真实盛行率可能更高。

根据 GLOBOCAN (2021) 的数据，大肠直肠癌是消化系统中的棘手问题，2020 年全球新病例为 1,931,590 例。全球胃肠道疾病的迅速增加表明对智慧药丸的需求不断增长，智慧药丸在诊断和治疗中发挥至关重要的作用。

患者对微创手术的偏好不断增加，进一步推动了智慧药丸市场的发展。智慧药丸具有独特的优势，例如先进的胶囊内视镜检查、精确的药物传输和无缝的远端患者监测。这些特性有助于智慧药丸在胃肠道疾病和癌症的治疗范例中得到越来越多的采用。

产业进入者对研发 (R&D) 的大量投资以及联盟和收购等策略举措进一步推动了市场动态。一个着名的例子是 EtectRx 与 Pear Therapeutics 于 2021 年 1 月建立的合作关係。该合作伙伴关係旨在整合嵌入药物和数位疗法中的无线感测器，将药物依从性数据与创新治疗方法相结合。

总之，由于胃肠道疾病盛行率上升、患者转向微创手术以及行业的策略性举措，智慧药丸市场预计将在 2024 年至 2030 年出现强劲增长。持续的技术进步以及研究和伙伴关係方面的协作努力证明了智慧药丸在应对不断变化的胃肠道医学领域的变革潜力。

本报告提供了全球智慧药丸市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章 智慧药丸市场报告简介

第二章智慧药丸市场概要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章智能药丸市场关键因素分析

  • 智慧药丸市场的驱动因素
  • 智慧药丸市场的限制与挑战
  • 智慧药丸市场机遇

第五章智慧药丸市场波特五力分析

第六章 智慧药丸市场布局

  • 依产品
    • 胶囊
    • 软体、配件
  • 依用途
    • 胶囊内窥镜
    • 病人监护
    • 给药
  • 依疾病分类
    • 克罗恩病
    • 小肠肿瘤
    • 遗传性息肉症候群
    • 胃肠道出血
    • 其他
  • 依最终用户
    • 医院/诊所
    • 诊断中心
  • 区域
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第七章智慧药丸市场公司与产品概况

  • Medtronic
  • Capso Vision Inc.
  • Olympus America
  • Hoya (Pentax Medical)
  • etectRx
  • Check-Cap
  • INTROMEDIC
  • HQ, Inc.
  • Koninklijke Philips N.V.
  • Novartis AG
  • BodyCAP
  • Medisafe
  • Otsuka America Pharmaceutical, Inc.
  • JINSHAN Science &Technology
  • Proteus Digital Health, Inc.
  • AnX Robotics.
  • Medimetrics S.A. de C.V.
  • BioCam
  • BDD Limited
  • RF Co., Ltd.

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明，联络我们

Product Code: DIMDCL0690

Smart Pills Market By Product (Capsules And Software And Accessories), Application (Capsule Endoscopy [Small Bowel Video Capsule Endoscopy And Colon Capsule Endoscopy], Patient Monitoring, And Drug Delivery), Disease (Crohn's Disease, Small Bowel Tumors, Inherited Polyposis Syndromes, GI Bleeding, And Others), End-Users (Hospitals & Clinics, Diagnostic Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of gastrointestinal diseases and the increasing demand of minimally invasive approaches across the globe

The global smart pills market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 11.34% during the forecast period from 2024 to 2030. A confluence of factors propels the demand for smart pills, with a notable impact stemming from the rising geriatric population and the escalating incidence of lifestyle-related diseases such as cancer and diabetes. This demographic shift is creating a pressing need for advanced healthcare solutions, thereby fostering the adoption of smart pills.

Moreover, the market is set to benefit from heightened research and development endeavors, coupled with increased funding dedicated to smart pill innovation. Technological strides, including the integration of micro-cameras, miniaturization, and the widespread availability of advanced microprocessors, are pivotal in augmenting the overall market landscape. These technological enhancements enhance the diagnostic and therapeutic capabilities of smart pills, positioning them as vital tools in modern healthcare.

The surge in demand for minimally invasive procedures and a growing emphasis on patient convenience further amplify the market's trajectory. The convergence of these factors not only propels the market forward but also underscores the transformative potential of smart pills in revolutionizing medical diagnostics and treatment methodologies.

Furthermore, the smart pills market is poised for sustained growth due to an influx of new product launches and approvals. The dynamic landscape is characterized by an increasing focus on addressing unmet medical needs through innovative solutions, thereby driving the market's expansion. The forecast period from 2024 to 2030 is expected to witness a robust ecosystem of smart pill offerings, contributing significantly to the overall growth and development of this transformative segment within the healthcare industry.

Smart Pills Market Dynamics:

The burgeoning prevalence of diverse gastrointestinal diseases globally is poised to significantly boost the smart pills market. A compelling illustration is provided by recent data from the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA), revealing that a staggering 10 million individuals worldwide grapple with Inflammatory Bowel Disease (IBD). Furthermore, the National Institute for Health and Care Excellence underscores the gravity of the situation, reporting that Irritable Bowel Syndrome (IBS) typically emerges between ages 20 and 30 in the United Kingdom, with a prevalence of 10% to 20% in the general population annually. Alarmingly, it is believed that many with IBS symptoms forego medical consultation, indicating a potentially higher true prevalence.

Colorectal cancer, a formidable gastrointestinal challenge, saw 1,931,590 new global cases in 2020 according to GLOBOCAN 2021. This collective surge in gastrointestinal ailments globally underscores the escalating demand for smart pills, which play a pivotal role in both diagnosis and treatment.

The growing preference for minimally invasive procedures among patients propels the smart pills market further. Smart pills offer distinctive advantages such as advanced capsule endoscopy, precise drug delivery, and seamless remote patient monitoring. These attributes contribute to the increasing adoption of smart pills in the treatment paradigm for gastrointestinal diseases and cancer.

Market dynamics are further catalyzed by substantial investments in Research and Development (R&D) by industry players, coupled with strategic initiatives like partnerships and acquisitions. A noteworthy example is the collaboration between EtectRx and Pear Therapeutics in January 2021. This partnership aims to integrate wireless sensors embedded in medications with digital therapeutics, combining medication adherence data with innovative therapeutic approaches.

In conclusion, the confluence of rising gastrointestinal disease prevalence, the patient shift towards minimally invasive procedures, and strategic industry initiatives position the smart pills market for robust growth from 2024 to 2030. The continual advancements in technology and concerted efforts in research and partnerships underscore the transformative potential of smart pills in addressing the evolving landscape of gastrointestinal healthcare.

However, risks related to the smart pills, the high costs associated with the device, and others may restrict the growth of the overall smart pills market.

Smart Pills Market Segment Analysis:

Smart pills Market by Product (Capsules and Software and Accessories), Application (Capsule Endoscopy [Small Bowel Video Capsule Endoscopy and Colon Capsule Endoscopy], Patient Monitoring, and Drug Delivery), Disease (Crohn's Disease, Small Bowel Tumors, Inherited Polyposis Syndromes, GI Bleeding, and Others), End-Users (Hospitals & Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Within the application segment of the smart pills market, the small bowel video capsule endoscopy category is poised to capture a substantial revenue share in 2023, driven by its inherent advantages and diverse applications. Small bowel video capsule endoscopy is a non-invasive procedure employing a miniature wireless camera to capture images of the digestive tract, particularly the small intestine. This innovative approach involves the patient swallowing a capsule, akin to a large pill, housing a camera.

The miniature camera within the small bowel video capsule endoscopy system, encapsulated in a vitamin-sized pill, travels through the digestive tract, capturing thousands of images transmitted to a recorder worn on a belt around the patient's waist. Not only does this procedure offer a detailed view of the small intestine, but it also eliminates the need for invasive measures, aligning with the growing trend towards minimally invasive healthcare technologies.

Furthermore, ongoing advancements in small bowel video capsule endoscopes, particularly in batteries and onboard memory, contribute to their suitability for prolonged usage, enhancing diagnostic capabilities. The market benefits from the presence of technologically advanced devices designed for optimal visualization of the small intestine. For instance, CapsoCam Plus, a product by CapsoVision, stands out by providing a full 360º panoramic direct lateral view of the small bowel mucosa, thereby improving diagnostic accuracy.

The momentum in this segment is further fueled by a series of product launches, regulatory approvals, and strategic initiatives. A notable instance is Medtronic plc's PillCam Small Bowel 3 system, which received clearance from the United States Food and Drug Administration (FDA) in November 2021 for remote endoscopy procedures. The ingestible camera in this capsule facilitates comprehensive visualization of the small bowel, exemplifying the continuous innovation within the field.

In light of these factors, the small bowel video capsule endoscopy category is anticipated to experience substantial growth, contributing significantly to the overall expansion of the smart pills market throughout the forecast period. The convergence of technological advancements, non-invasiveness, and strategic industry moves positions this category as a key driver in shaping the future landscape of smart medical solutions.

North America is expected to dominate the overall Smart Pills Market:

In the year 2023, North America is anticipated to secure the leading share in the smart pills market, driven by several pivotal factors that underscore the region's prominence. The prevalence of chronic diseases, particularly gastrointestinal ailments and associated cancers, stands out as a key growth driver. This is substantiated by the International Foundation for Gastrointestinal Disorders (IFFGD) 2021 report, revealing that 25 to 45 million individuals in the United States were affected by irritable bowel syndrome during that year.

The region's receptiveness to technologically advanced solutions, aiming to streamline patient care, plays a crucial role. The widespread adoption of such solutions is facilitated by a large and discerning customer base, further complemented by the rapidly growing geriatric population. Regulatory approvals for innovative devices, coupled with heightened awareness regarding disease diagnosis through smart pill technology, further contribute to the region's prosperous outlook.

The International Foundation for Gastrointestinal Disorders (IFFGD) report highlights the escalating burden of Inflammatory Bowel Disease (IBD) in Canada, projecting an increase from 322,600 people affected in 2023 to 470,000 in 2035. This trend underscores the growing demand for smart pills for both diagnosis and treatment in response to the rising prevalence of gastrointestinal diseases.

Notably, the region benefits from the presence of key industry players, fostering a conducive environment for product development activities. Additionally, the United States Food and Drug Administration (FDA) has been instrumental in shaping the market trajectory by granting approvals for innovative technologies. An illustrative example is the FDA's clearance in December 2019 for etectRx's ID-CAP System - a pill embedded with sensors that wirelessly communicates with an external system, revolutionizing remote health monitoring without physical contact.

In light of these factors, the smart pills market in North America is poised for substantial growth during the forecast period from 2024 to 2030. The confluence of increasing disease prevalence, regulatory support, technological advancements, and a robust healthcare ecosystem positions the region as a pivotal player in driving the evolution of smart medical solutions.

Smart Pills Market Key Players:

Some of the key market players operating in the smart pills market include Medtronic, Capso Vision Inc., Olympus America, Hoya (Pentax Medical), etectRx, Check-Cap, INTROMEDIC, HQ, Inc., Koninklijke Philips N.V., Novartis AG, BodyCAP, Medisafe, Otsuka America Pharmaceutical, Inc., JINSHAN Science & Technology, Proteus Digital Health, Inc., AnX Robotics, Medimetrics S.A. de C.V., BioCam, BDD Limited, RF Co., Ltd., and others.

Recent Developmental Activities in the Smart Pills Market:

  • In February 2023, AnX Robotica Corp. (US) launched the NaviCam Small Bowel System in the US. The NaviCam SB System utilizes aspherical lens technology to reduce distortion and enhance the field of vision, a critical component in the diagnosis of small bowel disease.
  • In 2021, Check-Cap (Israel) expanded C-Scan's manufacturing capacity and on-premises production line, while also remedying technical issues from a single source supplier. The company significantly expanded its production line to support its US pivotal study.
  • In June 2020, AnX Robotica Corp. was granted by the FDA De-Novo classification for its NaviCam Magnetically Controlled Capsule Endoscopy (MCCE) System. It is the first-of-its-kind system that allows complete, real-time visualization of the stomach utilizing a pill-sized capsule containing a camera and is remote-controlled by the physician using proprietary magnetic technologies.
  • In December 2020, CapsoVision Inc., achieved the International Standard Organization (ISO) 27001 security certification. The scope of the certification includes CapsoVision's headquarters and the company's CapsoCloud software. This certification validates the company's long-term commitment to the protection of customer data.

Key Takeaways from the Smart Pills Market Report Study

  • Market size analysis for current smart pills market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global smart pills market.
  • Various opportunities available for the other competitors in the smart pills market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current smart pills market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for smart pills market growth in the coming future?

Target Audience who can be benefited from this Smart Pills Market Report Study

  • Smart pill product providers
  • Research organizations and consulting companies
  • Smart pills-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in smart pills
  • Various End-users who want to know more about the smart pills market and the latest technological developments in the smart pills market.

Frequently Asked Questions for the Smart Pills Market:

1. What are smart pills?

Smart pills, also known as digital pills or ingestible sensors, are medical capsules or tablets that contain embedded sensors, cameras, or other monitoring devices. These technological components allow the smart pills to collect and transmit data about physiological conditions, medication adherence, and other relevant information from inside the human body. The primary purpose of smart pills is to enhance medical diagnostics, patient monitoring, and drug delivery. They are designed to provide healthcare professionals with real-time information about a patient's health status and response to medication.

2. What is the market for global smart pills?

The global smart pills market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 11.34% during the forecast period from 2024 to 2030.

3. What are the drivers for the global smart pills market?

The demand for smart pills is primarily being boosted by the increasing prevalence of increasing prevalence of chronic diseases, high demand for minimally invasive procedures, an increase in focus on patient convenience, technological development including miniaturization of integrated circuits, increasing product launches and approvals, and others thereby contributing to the overall growth of the smart pills market during the forecast period from 2024-2030.

4. Who are the key players operating in the global smart pills market?

Some of the key market players operating in the smart pills market include Medtronic, Capso Vision Inc., Olympus America, Hoya (Pentax Medical), etectRx, Check-Cap, INTROMEDIC, HQ, Inc., Koninklijke Philips N.V., Novartis AG, BodyCAP, Medisafe, Otsuka America Pharmaceutical, Inc., JINSHAN Science & Technology, Proteus Digital Health, Inc., AnX Robotics, Medimetrics S.A. de C.V., BioCam, BDD Limited, RF Co., Ltd., and others.

5. Which region has the highest share in the smart pills market?

North America is expected to dominate the overall smart pills market during the forecast period from 2024-2030. Owing to factors such as the rising prevalence of chronic diseases and gastrointestinal diseases and related cancers, wide acceptance of technologically advanced solutions to make patient care hassle-free, a large pool of customers, a rapidly growing geriatric population, regulatory approval for new devices, and high awareness about the diagnosis of the disease using smart pill technology among others, the North America smart pills market is expected to growth in coming years.

Table of Contents

1. Smart Pills Market Report Introduction

2. Smart Pills Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Smart Pills Market Key Factors Analysis

  • 4.1. Smart Pills Market Drivers
    • 4.1.1. Increasing prevalence of gastrointestinal disorders
    • 4.1.2. Surging Preference for minimally-invasive device
    • 4.1.3. Technological advancements about smart pills
  • 4.2. Smart Pills Market Restraints and Challenges
    • 4.2.1. Risks related to the smart pills
    • 4.2.2. High cost associated with the device
  • 4.3. Smart Pills Market Opportunities
    • 4.3.1. Growing demand for advanced drug delivery system
    • 4.3.2. Increasing R&D investments and intensive product pipelines

5. Smart Pills Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Smart Pills Market Layout

  • 6.1. By Product
    • 6.1.1. Capsules
    • 6.1.2. Software and Accessories
  • 6.2. By Application
    • 6.2.1. Capsule Endoscopy
      • 6.2.1.1. Small Bowel Video Capsule Endoscopy
      • 6.2.1.2. Colon Capsule Endoscopy
    • 6.2.2. Patient Monitoring
    • 6.2.3. Drug Delivery
  • 6.3. By Disease
    • 6.3.1. Crohn's Disease
    • 6.3.2. Small Bowel Tumors
    • 6.3.3. Inherited Polyposis Syndromes
    • 6.3.4. GI bleeding
    • 6.3.5. Others
  • 6.4. By End-Users
    • 6.4.1. Hospitals & Clinics
    • 6.4.2. Diagnostic Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America
      • 6.5.1.1. United States Smart Pills Market Size in USD million (2021-2030)
      • 6.5.1.2. Canada Smart Pills Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Smart Pills Market Size in USD million (2021-2030)
    • 6.5.2. Europe
      • 6.5.2.1. France Smart Pills Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Smart Pills Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Smart Pills Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Smart Pills Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Smart Pills Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Smart Pills Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific
      • 6.5.3.1. China Smart Pills Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Smart Pills Market Size in USD million (2021-2030)
      • 6.5.3.3. India Smart Pills Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Smart Pills Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Smart Pills Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Smart Pills Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW)
      • 6.5.4.1. Middle East Smart Pills Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Smart Pills Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Smart Pills Market Size in USD million (2021-2030)

7. Smart Pills Market Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Capso Vision Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Olympus America
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Hoya (Pentax Medical)
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. etectRx
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Check-Cap
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. INTROMEDIC
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. HQ, Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Koninklijke Philips N.V.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Novartis AG
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. BodyCAP
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Medisafe
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Otsuka America Pharmaceutical, Inc.
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. JINSHAN Science & Technology
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Proteus Digital Health, Inc.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. AnX Robotics.
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Medimetrics S.A. de C.V.
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. BioCam
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. BDD Limited
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. RF Co., Ltd.
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Smart Pills Market in Global (2021-2030)
  • Table 3: Smart Pills Market in Global by Product (2021-2030)
  • Table 4: Smart Pills Market in Global by Application (2021-2030)
  • Table 5: Smart Pills Market in Global by Disease (2021-2030)
  • Table 6: Smart Pills Market in Global by End-User (2021-2030)
  • Table 7: Smart Pills Market in Global by Geography (2021-2030)
  • Table 8: Smart Pills Market in North America (2021-2030)
  • Table 9: Smart Pills Market in the US (2021-2030)
  • Table 10: Smart Pills Market in Canada (2021-2030)
  • Table 11: Smart Pills Market in Mexico (2021-2030)
  • Table 12: Smart Pills Market in Europe (2021-2030)
  • Table 13: Smart Pills Market in France (2021-2030)
  • Table 14: Smart Pills Market in Germany (2021-2030)
  • Table 15: Smart Pills Market in the United Kingdom (2021-2030)
  • Table 16: Smart Pills Market in Italy (2021-2030)
  • Table 17: Smart Pills Market in Spain (2021-2030)
  • Table 18: Smart Pills Market in the Rest of Europe (2021-2030)
  • Table 19: Smart Pills Market in Asia-Pacific (2021-2030)
  • Table 20: Smart Pills Market in China (2021-2030)
  • Table 21: Smart Pills Market in Japan (2021-2030)
  • Table 22: Smart Pills Market in India (2021-2030)
  • Table 23: Smart Pills Market in Australia (2021-2030)
  • Table 24: Smart Pills Market in South Korea (2021-2030)
  • Table 25: Smart Pills Market in the Rest of Asia-Pacific (2021-2030)
  • Table 26: Smart Pills Market in the Rest of the World (2021-2030)
  • Table 27: Smart Pills Market in the Middle East (2021-2030)
  • Table 28: Smart Pills Market in Africa (2021-2030)
  • Table 29: Smart Pills Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Smart Pills Market in Global (2021-2030)
  • Figure 3: Smart Pills Market in Global by Product (2021-2030)
  • Figure 4: Smart Pills Market in Global by Application (2021-2030)
  • Figure 5: Smart Pills Market in Global by Disease (2021-2030)
  • Figure 6: Smart Pills Market in Global by End-User (2021-2030)
  • Figure 7: Smart Pills Market in Global by Geography (2021-2030)
  • Figure 8: Smart Pills Market in North America (2021-2030)
  • Figure 9: Smart Pills Market in the US (2021-2030)
  • Figure 10: Smart Pills Market in Canada (2021-2030)
  • Figure 11: Smart Pills Market in Mexico (2021-2030)
  • Figure 12: Smart Pills Market in Europe (2021-2030)
  • Figure 13: Smart Pills Market in France (2021-2030)
  • Figure 14: Smart Pills Market in Germany (2021-2030)
  • Figure 15: Smart Pills Market in the United Kingdom (2021-2030)
  • Figure 16: Smart Pills Market in Italy (2021-2030)
  • Figure 17: Smart Pills Market in Spain (2021-2030)
  • Figure 18: Smart Pills Market in the Rest of Europe (2021-2030)
  • Figure 19: Smart Pills Market in Asia-Pacific (2021-2030)
  • Figure 20: Smart Pills Market in China (2021-2030)
  • Figure 21: Smart Pills Market in Japan (2021-2030)
  • Figure 22: Smart Pills Market in India (2021-2030)
  • Figure 23: Smart Pills Market in Australia (2021-2030)
  • Figure 24: Smart Pills Market in South Korea (2021-2030)
  • Figure 25: Smart Pills Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 26: Smart Pills Market in the Rest of the World (2021-2030)
  • Figure 27: Smart Pills Market in the Middle East (2021-2030)
  • Figure 28: Smart Pills Market in Africa (2021-2030)
  • Figure 29: Smart Pills Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis